Page last updated: 2024-08-22

chloropyramine and Carcinoma, Pancreatic Ductal

chloropyramine has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bshara, W; Cance, WG; He, DH; Hunt, D; Kurenova, E; Liao, J; Seshadri, M; Yemma, M	1

Other Studies

1 other study(ies) available for chloropyramine and Carcinoma, Pancreatic Ductal

Article	Year
The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. Oncotarget, 2013, Volume: 4, Issue:10 Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Ethylenediamines; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; MAP Kinase Signaling System; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylation; Prognosis; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays	2013

Article

Year

The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.

Oncotarget, 2013, Volume: 4, Issue:10

Topics: Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Ethylenediamines; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; MAP Kinase Signaling System; Mice; Mice, SCID; Pancreatic Neoplasms; Phosphorylation; Prognosis; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays

2013